Metabolomics and lipidomics predictor of survival in hepatocellular carcinoma patients receiving tyrosine kinase inhibitor and immune checkpoint inhibitor combination therapy

Shaoxing Guan, Jinzhang Chen, Tu Xian et al.|Drug Metabolism and Disposition|2025

Cited by 2